REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $108,395 | -5.9% | 3,916 | -9.1% | 0.07% | -2.9% |
| Q2 2023 | $115,186 | +27.6% | 4,306 | +3.3% | 0.07% | +36.0% |
| Q1 2023 | $90,301 | -34.3% | 4,169 | -27.8% | 0.05% | -30.6% |
| Q4 2022 | $137,465 | +11.8% | 5,771 | -7.1% | 0.07% | +46.9% |
| Q3 2022 | $123,000 | +2.5% | 6,214 | +0.7% | 0.05% | +11.4% |
| Q2 2022 | $120,000 | -26.4% | 6,169 | -3.2% | 0.04% | -39.7% |
| Q1 2022 | $163,000 | -4.1% | 6,375 | -5.5% | 0.07% | +14.1% |
| Q4 2021 | $170,000 | +0.6% | 6,746 | +9.7% | 0.06% | -13.5% |
| Q3 2021 | $169,000 | -17.6% | 6,150 | -5.0% | 0.07% | -11.9% |
| Q2 2021 | $205,000 | -35.5% | 6,471 | -6.6% | 0.08% | -37.3% |
| Q1 2021 | $318,000 | +18.2% | 6,925 | +1.8% | 0.13% | +19.6% |
| Q4 2020 | $269,000 | -9.4% | 6,805 | -20.3% | 0.11% | -28.2% |
| Q3 2020 | $297,000 | -2.9% | 8,538 | -12.0% | 0.16% | +7.6% |
| Q2 2020 | $306,000 | – | 9,701 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $139,040,000 | 34.79% |
| Ponoi II Management, LLC | 685,011 | $17,242,000 | 31.32% |
| Nextech Invest Ltd. | 2,968,214 | $74,710,000 | 19.68% |
| Ponoi Management, LLC | 685,011 | $17,242,000 | 15.90% |
| Column Group LLC | 3,347,245 | $84,250,000 | 11.46% |
| TRV GP IV, LLC | 1,419,900 | $35,739,000 | 10.28% |
| Cormorant Asset Management, LP | 2,431,852 | $61,210,000 | 3.64% |
| Boxer Capital, LLC | 3,484,264 | $87,699,000 | 3.41% |
| Casdin Capital, LLC | 2,370,000 | $59,653,000 | 1.68% |
| BVF INC/IL | 1,810,549 | $45,572,000 | 1.65% |